Experts find “smorgasbord of tactics” used to boost sales during opioid addiction epidemic Opioid giant Mallinckrodt, selling more than Purdue Pharma in the US, was forced by the courts to publish more than 1.3 million internal documents. In The BMJ today, researchers Sergio Sismondo and Maud Bernisson sift through nearly 900 contracts ...
Landmark WHO resolution marks an important step towards a healthy world For the first time in the World Health Organization’s 76 year history, world leaders have unanimously committed to put social participation - people, communities and civil society - at the heart of health decision making processes. This landmark pledge ...
Patients’ concerns too often go ignored, says England’s first patient safety commissioner “The NHS’s relentless focus on finance and productivity is failing patient safety,” argues patient safety commissioner Henrietta Hughes in an interview for The BMJ today. “The patient’s anecdote is the canary in the coal mine,” she says. It’s the thing ...
Results highlight need to optimise speech therapy resources, say researchers An intensive voice treatment developed in the USA and known as the Lee Silverman voice treatment (LSVT LOUD) is more effective than conventional NHS speech and language therapy or no therapy for people with Parkinson’s disease, finds a trial published ...
Utrecht, 11 June 2024—The International Forum on Quality and Safety in Healthcare, which attracts 3,000 delegates annually, will be in Utrecht for the first time in 2025. Visitors from all over the world will come to Royal Dutch Jaarbeurs to gain knowledge and inspiration on improvement initiatives in patient care. ...
Practice highlights “critical loophole” in the revolving door between the FDA and industry The US Food and Drug Administration (FDA) tells staff leaving for industry jobs that, despite restrictions on post-employment lobbying, they are still permitted to influence the agency, reveals an investigation by The BMJ today. Internal emails, obtained under a ...
